<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20200424</date><key>pmc.key</key><document><id>1474522</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">1474522</infon><infon key="article-id_pmid">3289905</infon><infon key="fpage">29</infon><infon key="journal-title">Environmental Health Perspectives</infon><infon key="lpage">31</infon><infon key="name_0">surname:Bullock;given-names:B C</infon><infon key="name_1">surname:Newbold;given-names:R R</infon><infon key="name_2">surname:McLachlan;given-names:J A</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">77</infon><infon key="year">1988</infon><offset>0</offset><text>Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>87</offset><text>Cryptorchidism and retention of MÃ¼llerian duct structures occur with high frequency among the male offspring of CD-1 mice treated with 100 micrograms diethylstilbestrol/kg body weight on days 9 through 16 of pregnancy. Hyperplasia of the rete testis and MÃ¼llerian duct structures were found in many of the DES-treated male mice, as was a low but significant number of reproductive tract neoplasms.</text></passage></document></collection>
